Jo. Sandberg et al., 15-DEOXYSPERGUALIN PROLONGS PANCREATIC-ISLET ALLOGRAFT AND XENOGRAFT SURVIVAL IN MICE, Pharmacology & toxicology, 73(1), 1993, pp. 24-28
The new immunosuppressant 15-deoxyspergualin was evaluated in allogene
ic and xenogeneic pancreatic islet transplantation. In the allograft s
tudy 500 collagenase-isolated C57BL/6 mouse islets were transplanted u
nder the renal capsule of alloxan-diabetic C57BL/Ks mice that were eit
her 15-deoxyspergualin-treated (n=15) or given saline only (n=8). When
15-deoxyspergualin was given (5 mg/kg b.wt. intraperitoneally) until
day 28 after transplantation in a special dosage schedule, 10 out of 1
5 animals were normoglycaemic one week after transplantation and 6 wer
e still normoglycaemic after ten weeks, All 8 control animals were hyp
erglycaemic after 18 days. Light microscopy showed graft rejection in
hyperglycaemic mice, but only mild infiltration of lymphocytes in the
grafts of normoglycaemic animals. In the xenograft study C57BL/Ks mice
were transplanted under the renal capsule with 506-750 foetal porcine
islet-like cell clusters. The grafts were examined for evidence of re
jection with light microscopy at different time points after implantat
ion. In the control animals given saline only (n=37) there was progres
sive evidence of rejection starting on day seven. In 15-deoxysperguali
n treated animals (2.5 mg/kg intraperitoneally; n=27) there was signif
icantly less infiltration at days 7, 14 and 21. After 32 days there wa
s, however, no difference between controls and 15-deoxyspergualin trea
ted mice. A doubling of the 15-deoxyspergualin dose (5.0 mg/kg intrape
ritoneally; n=5) did not further improve the survival of the xenograft
ed islet-like cell clusters. There was no synergistic effect when cycl
osporine A (12.5 mg/kg intraperitoneally) was added to the 15-deoxyspe
rgualin therapy (n=34). Cyclosporine A in itself wag inefficient (n=5)
in protecting the xenograft from rejection. Thus, 15-deoxyspergualin
treatment induced marked prolongation of graft survival in an allogene
ic adult islet transplant model (mouse to mouse) and delayed rejection
in a foetal xenogeneic (pig to mouse) islet transplant model.